# OBServaToIre interNational Des Patients AnTiphospholipidEs traités Par Anticoagulants Oraux Directs

> **NCT06929182** · — · NOT_YET_RECRUITING · sponsor: **Central Hospital, Nancy, France** · enrollment: 500 (estimated)

## Conditions studied

- Antiphospholipid Syndrome (APS)
- Direct Oral Anticoagulants (DOACs)
- Thrombotic and Bleeding Events
- Safety

## Interventions

- **OTHER:** "non-high risk" thrombotic APS patients treated with DOAC

## Key facts

- **NCT ID:** NCT06929182
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07-01
- **Primary completion:** 2035-07-01
- **Final completion:** 2035-07-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2025-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06929182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06929182, "OBServaToIre interNational Des Patients AnTiphospholipidEs traités Par Anticoagulants Oraux Directs". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06929182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*